Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015–20
Authors:
- 23 June 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 78 (8) , 1982-1991
Abstract
Global antimicrobial resistance (AMR) surveillance in Neisseria gonorrhoeae is essential. In 2017–18, only five (10.6%) countries in the WHO African Region reported to the WHO Global Gonococcal Antimicrobial Surveillance Programme (WHO GASP). Genomics enhances our understanding of gonococcal populations nationally and internationally, including AMR strain transmission; however, genomic studies from Africa are extremely scarce. We describe the gonococcal genomic lineages/sublineages, including AMR determinants, and baseline genomic diversity among strains in Uganda, Malawi and South Africa, 2015–20, and compare with sequences from Kenya and Burkina Faso. Gonococcal isolates cultured in Uganda (n = 433), Malawi (n = 154) and South Africa (n = 99) in 2015–20 were genome-sequenced. MICs were determined using ETEST. Sequences of isolates from Kenya (n = 159), Burkina Faso (n = 52) and the 2016 WHO reference strains (n = 14) were included in the analysis. Resistance to ciprofloxacin was high in all countries (57.1%–100%). All isolates were susceptible to ceftriaxone, cefixime and spectinomycin, and 99.9% were susceptible to azithromycin. AMR determinants for ciprofloxacin, benzylpenicillin and tetracycline were common, but rare for cephalosporins and azithromycin. Most isolates belonged to the more antimicrobial-susceptible lineage B (n = 780) compared with the AMR lineage A (n = 141), and limited geographical phylogenomic signal was observed. We report the first multi-country gonococcal genomic comparison from Africa, which will support the WHO GASP and WHO enhanced GASP (EGASP). The high prevalence of resistance to ciprofloxacin (and empirical use continues), tetracycline and benzylpenicillin, and the emerging resistance determinants for azithromycin show it is imperative to strengthen the gonococcal AMR surveillance, ideally including genomics, in African countries.Keywords
Funding Information
- Örebro County Council Research Committee
- Örebro University Hospital
This publication has 71 references indexed in Scilit:
- IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood PhylogeniesMolecular Biology and Evolution, 2014
- Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and FutureClinical Microbiology Reviews, 2014
- Trimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics, 2014
- Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational studyThe Lancet Infectious Diseases, 2014
- Neisseria gonorrhoeae Strain with High-Level Resistance to Spectinomycin Due to a Novel Resistance Mechanism (Mutated Ribosomal Protein S5) Verified in NorwayAntimicrobial Agents and Chemotherapy, 2013
- SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell SequencingJournal of Computational Biology, 2012
- Impact of Fluoroquinolone Resistance Mutations on Gonococcal Fitness and In Vivo Selection for Compensatory MutationsThe Journal of Infectious Diseases, 2012
- Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC‐MtrD‐MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitnessMolecular Microbiology, 2008
- Regulation of the MtrC‐MtrD‐MtrE Efflux‐Pump System Modulates the In Vivo Fitness ofNeisseria gonorrhoeaeThe Journal of Infectious Diseases, 2007
- Species status of Neisseria gonorrhoeae: evolutionary and epidemiological inferences from multilocus sequence typingBMC Biology, 2007